Primer on U.S. FDA's new 510(k) refuse to accept policy

January 23, 2013 by MassDevice

Global Medicine

By Stewart Eisenhart, Emergo Group

The US Food and Drug Administration's revised Refuse to Accept (RTA) policy (links to PDF document) for 510(k) applications that lack all required documentation is now in effect. Medical device manufacturers planning to undergo the premarket notification process should familiarize themselves with steps necessary to get their applications back on track in the event that they receive an RTA notice from the FDA.

Sponsored by Emergo Group

The agency's new RTA process is currently in effect, and involves an early review of 510(k) applications to determine whether they are "administratively complete," or contain all materials necessary for the regulator to conduct a substantive review. The RTA screening precedes the full-blown premarket notification review that determines 510(k) clearance of a device.

The FDA's RTA review process includes the following steps: